Breast cancer is the most commonly diagnosed cancer among women worldwide and represents a major public health concern due to ...

Triple negative breast cancer (TNBC): median overall survival (OS) of 13.9 months vs. 11.8 months for antibody drug conjugate Trodelvy (sacituzumab govitecan-hziy) and 6.9 months single agent ...

Imagine a drug that halts cancer without side effects or risks. That future may be a bit nearer thanks to recent research led ...

Case 1: Early-Stage Progesterone Receptor Positive Breast Cancer Patient: 45 yo premenopausal woman with stage II ER+/PR+ IDC. Result: Excellent response, no recurrence at 5 years.

Dr. Greg Vigna High progesterone receptor positivity linked to low-grade meningiomas, highlighting risks of Depo-Provera use Women who required a craniotomy for a progesterone receptor positive ...

Our study identifies progesterone receptors in the brain as one reason women are susceptible to migraines. Cyclical changes in progesterone levels during the menstrual cycle activate the receptor ...

Decision-making was influenced by patient values and did not vary by stage, race and ethnicity, or demographics.

Neither estrogen or progesterone receptors, called “hormone negative” or “HR-" What Hormone Receptor Test Results Mean. Your treatment choices may depend partly on the test results.